Construction of A Nomogram Prediction Model for PD-L1 Expression 
in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters

Background and objective In recent years, immunotherapy represented by programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly changed the status of non-small cell lung cancer (NSCLC) treatment. PD-L1 has become an important biomarker for screening NSCLC...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Luoluo HAO, Lifeng WANG, Mengyao ZHANG, Jiaming YAN, Feifei ZHANG
Natura:	Artigo
Lingua:	Chinês
Pubblicazione:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2023-11-01
Serie:	Chinese Journal of Lung Cancer
Soggetti:	lung neoplasms 18f-fdg pet/ct metabolic parameters programmed cell death ligand 1 nomogram
Accesso online:	http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.32
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!